Breast Cancer Subtypes Identified by the ER, PR and HER-2 Status in Thai Women |
Chuthapisith, Suebwong
(Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University)
Permsapaya, Watthanasak (Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University) Warnnissorn, Malee (Department of Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University) Akewanlop, Charuwan (Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University) Sirivatanauksorn, Vorapan (Department of Biochemistry, Faculty of Medicine Siriraj Hospital, Mahidol University) Osoth, Poramaporn Prasarttong (Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University) |
1 | Carey LA, Perou CM, Livasy CA, et al (2006). Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA, 295, 2492-502. DOI ScienceOn |
2 | Goldhirsch A, Ingle JN, Gelber RD, et al (2009). Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Ann Oncol, 20, 1319-29. DOI |
3 | Goldhirsch A, Wood WC, Coates AS, et al (2011). Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol, 22, 1736-47. DOI ScienceOn |
4 | Hudis CA, Gianni L (2011). Triple-negative breast cancer: an unmet medical need. Oncologist, 16, 1-11. |
5 | Ihemelandu CU, Naab TJ, Mezghebe HM, et al (2008). Treatment and survival outcome for molecular breast cancer subtypes in black women. Ann Surg, 247, 463-9. DOI |
6 | Kostopoulou E, Vageli D, Kaisaridou D, et al (2007) Comparative evaluation of non-informative HER-2 immunoreactions (2+) in breast carcinomas with FISH, CISH and QRT-PCR. Breast, 16, 615-24. DOI ScienceOn |
7 | Kyndi M, Sorensen FB, Knudsen H, et al (2008). Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group. J Clin Oncol, 26, 1419-26. DOI ScienceOn |
8 | Nguyen PL, Taghian AG, Katz MS, et al (2008). Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol, 26, 2373-8. DOI |
9 | Sorlie T, Perou CM, Tibshirani R, et al (2001). Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA, 98, 10869-74. DOI ScienceOn |
10 | Sorlie T, Tibshirani R, Parker J, et al (2003). Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA, 100, 8418-23. DOI |
11 | Wiechmann L, Sampson M, Stempel M, et al (2009). Presenting features of breast cancer differ by molecular subtype. Ann Surg Oncol, 16, 2705-10. DOI |
12 | Sotiriou C, Neo SY, McShane LM, et al (2003). Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci USA, 100, 10393-8. DOI |
13 | Voduc KD, Cheang MC, Tyldesley S, et al (2010). Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol, 28, 1684-91. DOI |